Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 436 AL 450

Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study

Rentz DM, Rosenberg PB, Sperling RA, Donohue MC, Raman R, Liu A, Aisen PS.

J Prev Alzheimers Dis. 2024;11(4):814-822. doi: 10.14283/jpad.2024.123.

Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical Trial

Yaari R, Holdridge KC, Mancini M, Rafii MS, Case M, Battioui C, Sims JR, Aisen PS, Sperling RA.

J Prev Alzheimers Dis. 2024;11(4):857-868. doi: 10.14283/jpad.2024.138.

Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease

Shirzadi Z, Schultz AP, Properzi M, Yaari R, Yau WW, Brickman AM, Rafii MS, Donohue MC, Ernstrom K, Wang S, Jack CR Jr, Greenberg SM, Raman R, Aisen P, Sperling RA, Chhatwal JP.

J Prev Alzheimers Dis. 2024;11(4):869-873. doi: 10.14283/jpad.2024.139.

A Framework for Best Practices and Readiness in the Advent of Anti-Amyloid Therapy for Early Alzheimer's Disease in Asia

Lee JH, Jia J, Ji Y, Kandiah N, Kim S, Mok V, Pai MC, Senanarong V, Suh CH, Chen C.

J Alzheimers Dis. 2024;101(1):1-12. doi: 10.3233/JAD-240684.

Diagnosis and therapy of Alzheimer's disease: Light-driven heterogeneous redox processes

Chen W, Li J, Guo J, Li L, Wu H.

Adv Colloid Interface Sci. 2024 Oct;332:103253. doi: 10.1016/j.cis.2024.103253. Epub 2024 Jul 23.

Nanozymes in Alzheimer's disease diagnostics and therapy

Li L, Zhang W, Cao H, Fang L, Wang W, Li C, He Q, Jiao J, Zheng R.

Biomater Sci. 2024 Sep 10;12(18):4519-4545. doi: 10.1039/d4bm00586d.

Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood-Brain Barrier Crossing Ability

Song Q, Li J, Li T, Li HW.

Adv Sci (Weinh). 2024 Oct;11(38):e2403473. doi: 10.1002/advs.202403473. Epub 2024 Aug 5.

Cancer research provides a model for advancing clinical trials in dementia in the era of disease-modifying Alzheimer's-type dementia therapies

Jicha GA, Tucker TC, Arnold SM, Nelson PT.

Alzheimers Res Ther. 2024 Aug 21;16(1):184. doi: 10.1186/s13195-024-01532-6.

Case Definition for Diagnosed Alzheimer Disease and Related Dementias in Medicare

Gianattasio KZ, Wachsmuth J, Murphy R, Hartzman A, Montazer J, Cutroneo E, Wittenborn J, Power MC, Rein DB.

JAMA Netw Open. 2024 Sep 3;7(9):e2427610. doi: 10.1001/jamanetworkopen.2024.27610.

MicroRNAs: pioneering regulators in Alzheimer's disease pathogenesis, diagnosis, and therapy

Li YB, Fu Q, Guo M, Du Y, Chen Y, Cheng Y.

Transl Psychiatry. 2024 Sep 10;14(1):367. doi: 10.1038/s41398-024-03075-8.

Morphometry of medial temporal lobe subregions using high-resolution T2-weighted MRI in ADNI3: Why, how, and what's next?

Yushkevich PA, Ittyerah R, Li Y, Denning AE, Sadeghpour N, Lim S, McGrew E, Xie L, DeFlores R, Brown CA, Wisse LEM, Wolk DA, Das SR; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Nov;20(11):8113-8128. doi: 10.1002/alz.14161. Epub 2024 Sep 16.

Alzheimer Disease: Treatment of Cognitive and Functional Symptoms

Jaqua EE, Tran MN, Hanna M.

Am Fam Physician. 2024 Sep;110(3):281-293.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias